Disorders of glucose transport, unspecified
ICD-10 E74.819 is a billable code used to indicate a diagnosis of disorders of glucose transport, unspecified.
Disorders of glucose transport encompass a range of metabolic conditions characterized by impaired glucose uptake and utilization by cells. These disorders can arise from various underlying causes, including genetic mutations affecting glucose transporter proteins, enzyme deficiencies, and other metabolic dysfunctions. Patients may present with symptoms such as hypoglycemia, hyperglycemia, or metabolic acidosis, depending on the specific nature of the disorder. The glucose transporters, primarily GLUT1, GLUT2, and GLUT4, play critical roles in maintaining glucose homeostasis. Genetic defects in these transporters can lead to conditions like glucose transporter type 1 deficiency syndrome (GLUT1 DS), which is characterized by neurological symptoms due to insufficient glucose transport across the blood-brain barrier. Diagnosis typically involves biochemical tests, genetic testing, and clinical evaluation. Management strategies may include dietary modifications, supplementation, and in some cases, pharmacological interventions. Given the complexity of glucose metabolism and the potential for overlapping symptoms with other metabolic disorders, accurate coding is essential for appropriate treatment and reimbursement.
Detailed metabolic panel results, genetic testing outcomes, and treatment plans.
Patients presenting with unexplained hypoglycemia or hyperglycemia, requiring evaluation for glucose transport disorders.
Endocrinologists must ensure comprehensive documentation of metabolic assessments and any genetic evaluations performed.
Genetic test results, family history, and detailed clinical evaluations.
Patients with a family history of metabolic disorders or those presenting with symptoms suggestive of genetic glucose transport issues.
Geneticists should document the specific genetic mutations identified and their implications for treatment and family counseling.
Used in conjunction with E74.819 for evaluating glucose levels in suspected glucose transport disorders.
Document the reason for the glucose test and any relevant clinical findings.
Endocrinologists should ensure that glucose testing aligns with the patient's clinical presentation.
Common symptoms include hypoglycemia, hyperglycemia, seizures, developmental delays, and metabolic acidosis, depending on the specific disorder.
